We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ASM:EURONEXT AMSTERDAMASM International N.V. Analysis

Data as of 2026-06-01 - not real-time

$7.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical momentum remains positive – the 20‑day SMA sits above the 50‑day and 200‑day averages, the MACD histogram is bullish and the RSI hovers around a neutral 55, keeping the stock comfortably above its $6.20 support yet still below the $8.19 resistance. Fundamentally, ASM delivers strong margins (gross ~55%, operating ~49%) and solid cash generation, with a trailing EPS of $0.22 and a forward EPS of $0.81, but a high trailing P/E of 33 versus a forward P/E of 9 suggests earnings are accelerating. The company’s DCF fair value of roughly $3.85 is well under the current $7.32 price, flagging potential overvaluation, while analyst sentiment is bullish – 75% of coverage recommends buying and consensus targets near $12 imply >50% upside. Recent material news adds a fresh catalyst: a 5% share‑repurchase program approved by the TSX, reinforcing capital allocation discipline and supporting the price.
Given the high beta (≈2.6), 30‑day volatility above 70%, and a historic max drawdown of over 50%, investors should weigh the upside from strong operational performance and buyback support against the elevated market risk and valuation stretch.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish short‑term technical setup but price above DCF fair value
  • Share‑repurchase program adds near‑term price support
  • High volatility and beta increase downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong operating margins and accelerating earnings (forward EPS)
  • Analyst consensus price target >50% upside
  • Buyback program signals confidence and may improve EPS

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained cash generation and low leverage provide financial stability
  • Exposure to precious‑metal price cycles and Mexican mining regulatory environment
  • Valuation remains stretched relative to DCF, tempering long‑term upside

Key Metrics & Analysis

Financial Health

Revenue Growth109.30%
Profit Margin32.74%
P/E Ratio33.3
ROE18.12%
ROA12.48%
Debt/Equity3.03
P/B Ratio4.5
Op. Cash Flow$40.3M
Free Cash Flow$15.0M

Technical Analysis

TrendBullish
RSI55.0
Support$6.20
Resistance$8.19
MA 20$6.96
MA 50$6.75
MA 200$6.33
MACDBullish
VolumeDecreasing
Fear & Greed Index92.96

Valuation

Fair Value$3.85
Target Price$11.31
Upside/Downside54.54%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.65
Volatility76.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.